Pages that link to "Item:Q3183236"
From MaRDI portal
The following pages link to A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents (Q3183236):
Displaying 9 items.
- A Bayesian adaptive design in cancer phase I trials using dose combinations in the presence of a baseline covariate (Q1733138) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Continual Reassessment Method for Partial Ordering (Q2893418) (← links)
- Application of gamma process to two-agent combinations with delayed toxicity (Q5083969) (← links)
- Flexible use of copula‐type model for dose‐finding in drug combination clinical trials (Q6055718) (← links)
- Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information (Q6085905) (← links)
- CRM and partial order CRM with adaptive rescaling for dose-finding in immunotherapy trials with a continuous outcome (Q6625779) (← links)
- A nonparametric Bayesian method for dose finding in drug combinations cancer trials (Q6626759) (← links)
- Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimens (Q6628011) (← links)
